April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Opposing Effects of IL-1 and TGFβ1 on Corneal Myofibroblast Viability in vitro
Author Affiliations & Notes
  • H. Kaur
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • S. S. Chaurasia
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • V. Agrawal
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • S. E. Wilson
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  H. Kaur, None; S.S. Chaurasia, None; V. Agrawal, None; S.E. Wilson, None.
  • Footnotes
    Support  NIH Grant EY10056 and EY15638 from National Eye Institute and Research to Prevent Blindness, New York, NY. Dr. Wilson is the recipient of a Research to Prevent Blindness Physician-Scientist Award.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4537. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Kaur, S. S. Chaurasia, V. Agrawal, S. E. Wilson; Opposing Effects of IL-1 and TGFβ1 on Corneal Myofibroblast Viability in vitro . Invest. Ophthalmol. Vis. Sci. 2009;50(13):4537.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To elucidate the effect of interleukin-1 and transforming growth factor beta-1 on corneal stromal myofibroblasts viability and death in vitro.

Methods: : Primary rabbit corneal fibroblasts were cultured with 2ng/ml of transforming growth factor-β1 (TGFβ1) to induce myofibroblast differentiation confirmed by monitoring -smooth muscle actin (-SMA) expression. Fluorescence-based TUNEL assay was performed to analyze the apoptotic response of myofibroblasts to IL-1 or IL-1β in the presence or absence of TGFβ1. Dose response experiments were performed after withdrawal of TGFβ1 and exposure to 1, 5, or 10 ng/ml of IL-1 or IL-1β for 1 hour. Subsequent experiments were performed with myofibroblasts exposed to 5 ng/ml IL-1 or IL-1β in conjunction with 0, 1, 5, or 10 ng/ml TGFβ1. Results 4 wells at each cytokine concentration at each time point were analyzed.

Results: : Exposure to TGFβ1 resulted in greater than 99% transformation of corneal fibroblasts to -SMA+ myofibroblasts. There was a statistically significant dose dependent increase in the percentage of TUNEL+ cells with either IL-1 or IL-1β at each time point (ANOVA, P<0.05). For example, in one experiment, after withdrawal of TGFβ1, the % TUNEL+ cells at 1 hour after exposure to IL-1 cytokine increased significantly with increasing concentration (0 ng/ml, 2.4±0.8 (S.E.M.) %; 1 ng/ml, 15.4±1.8%; 5 ng/ml, 47.4±3.9%; or 10 ng/ml, 70.3±3.2%). The differences between the means were significantly different (ANOVA p<0.001). Similarly, with IL-1β at 0 ng/ml, 1 ng/ml, 5 ng/ml or 10 ng/ml the % TUNEL+ cells significantly increased at 1 hour (2.4±0.8%, 12.8±0.7%, 53.5±4.1%, and 84.6±3.7%, respectively). The differences between the means were significantly different (ANOVA p<0.001). When myofibroblasts were exposed to 5 ng/ml IL-1 or IL-1β the % TUNEL+ cells at 1 hour was reduced in a dose dependent manner when TGFβ1 at a concentration of 0 ng/ml, 1 ng/ml, 5 ng/ml or 10 ng/ml TGFβ1 was present in the medium. The differences between the means were significantly different (ANOVA p<0.001).

Conclusions: : IL-1 or IL-1β triggers the death of myofibroblasts in vitro and TGFβ1 inhibits the IL-1 effect on cell death. The mechanism of IL-1 induced myofibroblast cell death is likely apoptosis.

Keywords: cornea: stroma and keratocytes • apoptosis/cell death • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×